Grant and Funding Programs Offered by Defeat Duchenne Canada (DDC)
Overview of Available Grants and Funding
Defeat Duchenne Canada is a national Canadian charity dedicated to ending Duchenne muscular dystrophy. It funds cutting-edge biomedical and clinical research, supports care and advocacy initiatives, and administers annual research grant programs that have invested over $20.3 million in 80+ projects in Canada and worldwide. View Defeat Duchenne Canada (DDC)'s website for more information.
Content last updated: March 24, 2026
About Defeat Duchenne Canada (DDC)
What is the mission of Defeat Duchenne Canada (DDC)?
Defeat Duchenne Canada’s mission is to end Duchenne muscular dystrophy by funding high-impact research, advancing better care and treatments, and supporting and advocating for families affected by the disease across Canada and beyond.
What type of organization is Defeat Duchenne Canada (DDC)?
Defeat Duchenne Canada (DDC) is a Non-profit organization.
When was Defeat Duchenne Canada (DDC) founded?
Defeat Duchenne Canada (DDC) was founded in 1995.
What is Defeat Duchenne Canada (DDC)'s official website?
Defeat Duchenne Canada (DDC)'s official website is https://defeatduchenne.ca/.
What else should I know about Defeat Duchenne Canada (DDC)?
Role of Defeat Duchenne Canada in the funding ecosystem
Defeat Duchenne Canada is the country’s only national charity focused exclusively on Duchenne muscular dystrophy. Since 1995, it has become the largest Canadian charitable source of investment in Duchenne research, combining fundraising from individuals, families and partners to support scientific innovation, clinical translation and improved care. The organization runs an annual research grant program and has, to date, funded more than $20.3 million across over 80 research projects in Canada and internationally.
Through its For Researchers and Research We Fund sections, Defeat Duchenne Canada describes a structured granting process, with regular calls for proposals, peer review by scientific experts and public announcements of funded projects. Grants support a wide range of activities, from basic and translational science to clinical trials, fellowships and knowledge translation initiatives that directly affect the quality of life of people living with Duchenne.
Funding themes and target communities
The organization prioritizes research that has a clear path to clinical impact. Thematic areas reflected on the site include:
- Gene-based therapies such as exon skipping, nonsense mutation read-through, gene therapy and gene editing (CRISPR/Cas9).
- Symptom-targeting approaches that protect or rebuild muscle, reduce inflammation and fibrosis, and improve mitochondrial and cardiac function.
- Clinical research and trials, including imaging biomarkers, real-world evidence, and long-term outcome tracking for neuromuscular diseases.
- Psychosocial and rehabilitation research, such as bullying prevention resources and care models that improve quality of life.
- Training and fellowships to build specialized clinical and research capacity in Duchenne endocrinology, bone health and respiratory care.
Funding is open to academics, clinicians and research teams at universities, hospitals and research institutes around the world, with many projects based in Canada, the United States and Europe. Families affected by Duchenne are highlighted as partners in shaping research priorities and participating in clinical studies.
General evaluation criteria and impact
While the site does not publish a detailed scoring rubric, its communications emphasize several recurrent principles: scientific excellence, potential for translation to clinical practice, relevance to urgent unmet needs in Duchenne, and feasibility within the proposed timeframe and budget. Funded projects are profiled in depth, outlining objectives, methods and expected benefits for patients, which reinforces transparency and accountability to donors and the community.
Defeat Duchenne Canada also collaborates with international organizations and co-funding partners on joint awards and fellowships, amplifying the reach of its grants. Annual “Research Grant Announcement” events and video updates allow donors and families to meet funded investigators and follow progress over time.
Supported audiences and overall impact
Beyond research funding, the charity invests in advocacy, education and direct support resources for families living with Duchenne and Becker muscular dystrophy. Its funding portfolio is therefore part of a broader strategy that includes navigating clinical trials, improving access to emerging therapies and strengthening standards of care. By combining multi-year grant programs with public engagement and strategic partnerships, Defeat Duchenne Canada plays a central role in the Canadian and international Duchenne funding ecosystem.